INCYTE CORPORATION Finance Lease, Liability, Undiscounted Excess Amount
INCYTE CORPORATION (INCY) had Finance Lease, Liability, Undiscounted Excess Amount of $6.73 million as of 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2026-02-10
- 2025-12-31: Finance Lease, Liability, Undiscounted Excess Amount $6.73M.
- 2024-12-31: Finance Lease, Liability, Undiscounted Excess Amount $6.97M.
- 2023-12-31: Finance Lease, Liability, Undiscounted Excess Amount $6.95M.
- 2022-12-31: Finance Lease, Liability, Undiscounted Excess Amount $8.00M.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $6.73M 10-K · filed 2026-02-10 |
| 2024-12-31 | $6.97M 10-K · filed 2025-02-10 |
| 2023-12-31 | $6.95M 10-K · filed 2024-02-13 |
| 2022-12-31 | $8.00M 10-K · filed 2023-02-07 |
| 2021-12-31 | $9.29M 10-K · filed 2022-02-08 |
| 2020-12-31 | $10.40M 10-K · filed 2021-02-09 |
| 2019-12-31 | $11.41M 10-K · filed 2020-02-13 |
| 2019-09-30 | $11.55M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $11.85M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $99.00K 10-Q · filed 2019-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |